Liens utiles

Institut National du Cancer agence d'expertise sanitaire et scientifique en cancérologie

Nota Bene Cancer bulletin de veille bibliographique dans les divers domaines de la recherche sur les cancers

Onco Actu brèves sur le web anglophone

 

Tous les liens utiles

Accueil » La R&D d'Unicancer » Les publications de la R&D d'Unicancer » Les publications

Publications de la R&D d'Unicancer

2018

Results of Methotrexate-Etoposide-Ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/Sarcome-09 study.

N. Gaspar et al, Eur J Cancer. 2018 Jan;88:57-66. doi: 10.1016/j.ejca.2017.09.036. Epub 2017 Nov 28.

2018

Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.

S. Supiot et al, Oncotarget. 2018 Apr 24;9(31):22147-22157. doi: 10.18632/oncotarget.25189. eCollection 2018 Apr 24.

2018

Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer.

C. Schuurhuizen et al, J Natl Compr Canc Netw. 2018 Dec;16(12):1481-1488. doi: 10.6004/jnccn.2018.7069.

2018

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.

G. Gravis et al, Eur Urol. 2018 Jun;73(6):847-855. doi: 10.1016/j.eururo.2018.02.001. Epub 2018 Feb 21.

2018

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.

P. Lavaud et al, Eur Urol. 2018 May;73(5):696-703. doi: 10.1016/j.eururo.2017.09.022. Epub 2017 Oct 23.

2018

Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey.

E. Paillaud et al, Eur J Cancer. 2018 Nov;103:61-68. doi: 10.1016/j.ejca.2018.07.137. Epub 2018 Sep 11.

2018

Rôle des gènes de la réparation de l’ADN dans la prédisposition génétique aux cancers du sein et implication pour les tests génétiques : résultats de l’étude cas-témoins GENESIS.

Girard Elodie et al, Assises de Génétique Humaine et Médicale.

2018

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study

Girard E. et al, BRCA Symposium.

2016

Analysing patients presenting an exceptional and unexpected response in oncology: recent initiatives [article in French]

Charles Ferté et al., ITO. 2016 Jun ; 2(3) :135-140.

2016

Equal access to innovative therapies and precision cancer care

Buzyn A et al., Nat Rev Clin Oncol. 2016 Jun;13(6):385-93